Loading chat...
US HB1947
Bill
Status
Introduced
3/6/2025
Primary Sponsor
Scott Perry
Click for details
AI Summary
- Secretary of Veterans Affairs must provide stellate ganglion block treatment to veterans enrolled in VA healthcare who have been diagnosed with PTSD and elect to receive the treatment after being informed of risks and benefits
- Secretary of Defense must provide the same stellate ganglion block treatment to active duty and reserve Armed Forces members enrolled in TRICARE who have PTSD and consent to treatment
- Treatment may be furnished through VA/DOD medical facilities or through qualified outside healthcare providers participating in VA community care or TRICARE networks
- VA and DOD must update the joint "VA/DOD Clinical Practice Guideline for the Management of PTSD" within 180 days to include stellate ganglion block as a therapy option with clinical indicators and contraindicators
- Provisions take effect 180 days after enactment, with required notification to congressional defense and veterans' affairs committees upon guideline update
Legislative Description
TREAT PTSD Act Treatment and Relief through Emerging and Accessible Therapy for PTSD Act
Armed forces and national security
Last Action
Referred to the Subcommittee on Health.
3/27/2025
Committee Referrals
Subcommittee on Health3/27/2025
Armed Services3/6/2025
Full Bill Text
No bill text available